估计与改善早期怀孕心血管健康预防的不良妊娠结果的比例
Jaclyn D Borrowman1, Xiaoning Huang1, Amanda M Perak2
1Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
JACC. Advances
|January 17, 2026
概括
在怀孕早期改善孕产妇心血管健康 (CVH) 可以显著减少不良妊娠结果 (APO). 研究表明,加强CVH可以防止大量的APO,强调产前健康干预的重要性.
科学领域:
- 产科和妇科 产科和妇科
- 心血管健康 心血管健康
- 公共卫生 公共卫生
背景情况:
- 有利的孕产妇心血管健康 (CVH) 与不良妊娠结果 (APO) 的风险降低有关.
- 了解改善CVH对APO的潜在影响对于产前护理策略至关重要.
研究的目的:
- 量化通过改善孕产妇心血管健康 (CVH) 可预防的不良妊娠结果 (APO) 的比例.
主要方法:
- 利用了来自无卵性妊娠结果研究 (N=8,927) 的数据,包括第一季度的CVH指标 (身体活动,饮食,睡眠,BMI,血压,尼古丁使用).
- 使用后勤回归评估了CVH得分和APO (高血压疾病,妊娠糖尿病,早产) 之间的关联.
- 通过假设的CVH改善场景估计APO的可预防部分.
主要成果:
- 较低的CVH得分与增加的APO风险显著相关 (aOR: 1.46).
- 假设的干预措施显示,通过提高得分到50的12%可以预防12%的APO,提高到80的15%,提高到100的40%可以预防12%的APO.
- 在改善的CVH和减少的APO之间观察到剂量反应关系,在APO亚型中一致.
结论:
- 在怀孕期间改善母亲的心血管健康为减少不良妊娠结果提供了相当大的潜在益处.
- 旨在加强孕产妇CVH的干预措施可能会对人口水平APO率产生重大影响.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
409
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
409
Regression Toward the Mean
6.9K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.9K
Coronary Artery Disease IV: Preventive Measures
591
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
591
Errors occurring during blood pressure monitoring
1.3K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
1.3K
Assessment of the Cardiovascular System I: Subjective Data
759
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
759
Mitral Valve Prolapse III: Nursing Management
292
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
292


